Pfizer filed suit against Impax Laboratories over one patent related to a pharmaceutical composition comprising a 3,3-diphenylpropylamine 5/31, District of New Jersey, 2:2011cv03130.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
